Answers are grounded in this paper and cite their sources.
Comprehensive review details pathogenicity and antifungal resistance of Cryptococcus in urban ecosystems, indicating urgent research needs.
Cryptococcosis is a potentially life-threatening fungal infection affecting the lungs and central nervous system and is primarily caused by Cryptococcus neoformans and Cryptococcus gattii. These pathogens are acquired through the inhalation of spores from contaminated environmental sources, such as bird droppings, tree hollows, and decaying wood. Serotype A of C. neoformans accounts for over 90% of global cases, whereas serotype D is more frequent in Europe. Although infections occur predominantly in immunocompromised individuals, immunocompetent hosts may also be affected. Once inhaled, the fungus evades immune defenses and disseminates to the meninges, leading to cryptococcal meningitis. Diagnostic approaches include environmental sampling, culturing in selective media, and identification using microscopic and molecular techniques. Antifungal susceptibility profiles revealed the effectiveness of fluconazole, itraconazole, voriconazole, posaconazole, amphotericin B, and flucytosine, whereas ketoconazole, miconazole, and echinocandins showed limited efficacy. Resistance, particularly to fluconazole and amphotericin B, may develop after prolonged treatment. This review also highlights research from Tamil Nadu focusing on airborne environmental sources and antifungal resistance patterns. Key gaps include a limited understanding of local environmental reservoirs, the molecular mechanisms driving resistance, and early diagnostic limitations. Addressing these issues is essential for improving therapeutic outcomes and guiding future epidemiological strategies.
No takes yet. Share an insight, caveat, or question.
Manogaran et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: